|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 456.22 USD | +1.21% |
|
-4.55% | -24.84% |
| 12:52pm | Argus Adjusts Price Target on Ulta Beauty to $550 From $615, Maintains Buy Rating | MT |
| 06-16 | Warpaint says trading "difficult", but signs of improvement ahead | AN |
| Fiscal Period: January | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 16.41 | 20.21 | 18.94 | 16.71 | 14.74 | |||||
Return on Total Capital | 22.21 | 28.27 | 26.05 | 22.74 | 20.39 | |||||
Return On Equity % | 55.78 | 71.09 | 60.91 | 50.39 | 43.59 | |||||
Return on Common Equity | 55.78 | 71.09 | 60.91 | 50.39 | 43.59 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 43.54 | 43.59 | 42.95 | 42.78 | 43.05 | |||||
SG&A Margin | 28.44 | 27.44 | 27.91 | 28.81 | 30.55 | |||||
EBITDA Margin % | 18.09 | 18.41 | 17.14 | 16.22 | 14.8 | |||||
EBITA Margin % | 14.99 | 16.05 | 14.97 | 13.85 | 12.37 | |||||
EBIT Margin % | 14.99 | 16.05 | 14.97 | 13.85 | 12.37 | |||||
Income From Continuing Operations Margin % | 11.42 | 12.17 | 11.52 | 10.63 | 9.31 | |||||
Net Income Margin % | 11.42 | 12.17 | 11.52 | 10.63 | 9.31 | |||||
Net Avail. For Common Margin % | 11.42 | 12.17 | 11.52 | 10.63 | 9.31 | |||||
Normalized Net Income Margin | 9.35 | 10.06 | 9.46 | 8.74 | 7.7 | |||||
Levered Free Cash Flow Margin | 8.85 | 9.69 | 6.99 | 6.86 | 7.26 | |||||
Unlevered Free Cash Flow Margin | 8.86 | 9.69 | 6.99 | 6.86 | 7.27 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.75 | 2.01 | 2.02 | 1.93 | 1.91 | |||||
Fixed Assets Turnover | 3.52 | 4.11 | 4.21 | 4.03 | 4.07 | |||||
Receivables Turnover (Average Receivables) | 40.45 | 47.14 | 55.02 | 52.38 | 47.71 | |||||
Inventory Turnover (Average Inventory) | 3.65 | 3.62 | 3.73 | 3.41 | 3.33 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.46 | 1.61 | 1.71 | 1.7 | 1.41 | |||||
Quick Ratio | 0.43 | 0.56 | 0.59 | 0.52 | 0.36 | |||||
Operating Cash Flow to Current Liabilities | 0.68 | 0.88 | 0.89 | 0.75 | 0.68 | |||||
Days Sales Outstanding (Average Receivables) | 9 | 7.72 | 6.74 | 6.95 | 7.63 | |||||
Days Outstanding Inventory (Average Inventory) | 99.62 | 100.64 | 99.34 | 106.83 | 109.31 | |||||
Average Days Payable Outstanding | 36.01 | 34.53 | 31.35 | 30.11 | 31.28 | |||||
Cash Conversion Cycle (Average Days) | 72.61 | 73.83 | 74.73 | 83.67 | 85.66 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 120.28 | 97.11 | 83.84 | 77.29 | 77.83 | |||||
Total Debt / Total Capital | 54.6 | 49.27 | 45.61 | 43.6 | 43.77 | |||||
LT Debt/Equity | 102.43 | 82.66 | 71.39 | 65.71 | 64.67 | |||||
Long-Term Debt / Total Capital | 46.5 | 41.93 | 38.83 | 37.06 | 36.37 | |||||
Total Liabilities / Total Assets | 67.77 | 63.51 | 60.06 | 58.54 | 59.95 | |||||
EBIT / Interest Expense | 777.79 | - | - | - | 857.86 | |||||
EBITDA / Interest Expense | 1.17K | - | - | - | 1.3K | |||||
(EBITDA - Capex) / Interest Expense | 1.07K | - | - | - | 1.06K | |||||
Total Debt / EBITDA | 0.95 | 0.83 | 0.81 | 0.84 | 0.94 | |||||
Net Debt / EBITDA | 0.73 | 0.51 | 0.49 | 0.54 | 0.73 | |||||
Total Debt / (EBITDA - Capex) | 1.04 | 0.97 | 1 | 1.01 | 1.16 | |||||
Net Debt / (EBITDA - Capex) | 0.8 | 0.59 | 0.6 | 0.64 | 0.89 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 40.3 | 18.28 | 9.78 | 0.79 | 9.71 | |||||
Gross Profit, 1 Yr. Growth % | 60.96 | 18.43 | 8.18 | 0.38 | 10.39 | |||||
EBITDA, 1 Yr. Growth % | 162.1 | 20.37 | 2.24 | -4.65 | 0.1 | |||||
EBITA, 1 Yr. Growth % | 332.98 | 26.68 | 2.41 | -6.74 | -2.04 | |||||
EBIT, 1 Yr. Growth % | 332.98 | 26.68 | 2.41 | -6.74 | -2.04 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 460.66 | 26.03 | 3.91 | -6.96 | -3.97 | |||||
Net Income, 1 Yr. Growth % | 460.66 | 26.03 | 3.91 | -6.96 | -3.97 | |||||
Normalized Net Income, 1 Yr. Growth % | 340.89 | 27.23 | 3.17 | -6.82 | -3.34 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 478.14 | 33.54 | 8.41 | -2.65 | 1.18 | |||||
Accounts Receivable, 1 Yr. Growth % | 21.01 | -14.66 | 4.27 | 7.4 | 32.63 | |||||
Inventory, 1 Yr. Growth % | 28.33 | 6.73 | 8.28 | 13.13 | 10.52 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.15 | 7.25 | 7.25 | 3.35 | 13.97 | |||||
Total Assets, 1 Yr. Growth % | -6.4 | 12.72 | 6.27 | 5.16 | 16.62 | |||||
Tangible Book Value, 1 Yr. Growth % | -23.32 | 27.88 | 16.45 | 9.23 | -4.18 | |||||
Common Equity, 1 Yr. Growth % | -23.21 | 27.64 | 16.3 | 9.17 | 12.66 | |||||
Cash From Operations, 1 Yr. Growth % | 30.72 | 39.9 | -0.38 | -9.32 | 12.26 | |||||
Capital Expenditures, 1 Yr. Growth % | 13.38 | 81.27 | 39.45 | -13.97 | 16.12 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 20.53 | 29.54 | -20.85 | -1.05 | 16.17 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 20.01 | 29.37 | -20.85 | -1.05 | 16.32 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.01 | 28.82 | 13.95 | 5.19 | 5.16 | |||||
Gross Profit, 2 Yr. CAGR % | 11.05 | 38.07 | 13.19 | 4.21 | 5.27 | |||||
EBITDA, 2 Yr. CAGR % | 14.26 | 70.28 | 10.79 | -1.27 | -2.3 | |||||
EBITA, 2 Yr. CAGR % | 19.81 | 116.02 | 13.72 | -2.27 | -4.42 | |||||
EBIT, 2 Yr. CAGR % | 19.81 | 116.02 | 13.72 | -2.27 | -4.42 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 18.17 | 165.82 | 14.44 | -1.68 | -5.48 | |||||
Net Income, 2 Yr. CAGR % | 18.17 | 165.82 | 14.44 | -1.68 | -5.48 | |||||
Normalized Net Income, 2 Yr. CAGR % | 19.4 | 118.13 | 14.39 | -1.95 | -5.09 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 21.65 | 177.85 | 20.32 | 2.73 | -0.75 | |||||
Accounts Receivable, 2 Yr. CAGR % | 29.5 | 1.62 | -5.67 | 5.83 | 19.35 | |||||
Inventory, 2 Yr. CAGR % | 7.65 | 18.63 | 7.5 | 10.68 | 11.82 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -6.53 | 1.39 | 7.25 | 5.28 | 8.53 | |||||
Total Assets, 2 Yr. CAGR % | -1.03 | 2.72 | 9.45 | 5.71 | 10.74 | |||||
Tangible Book Value, 2 Yr. CAGR % | -10.18 | -0.98 | 22.03 | 12.78 | 2.31 | |||||
Common Equity, 2 Yr. CAGR % | -10.16 | -1 | 21.84 | 12.68 | 10.9 | |||||
Cash From Operations, 2 Yr. CAGR % | -1.93 | 35.23 | 18.05 | -4.96 | 0.89 | |||||
Capital Expenditures, 2 Yr. CAGR % | -24.05 | 43.36 | 58.99 | 9.53 | -0.05 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 11.66 | 21.85 | 1.09 | -11.5 | 7.22 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 11.74 | 21.52 | 1.03 | -11.5 | 7.28 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.72 | 11.33 | 22.13 | 9.38 | 6.68 | |||||
Gross Profit, 3 Yr. CAGR % | 15.97 | 13.46 | 27.28 | 8.75 | 6.23 | |||||
EBITDA, 3 Yr. CAGR % | 11.27 | 16.26 | 43.65 | 5.38 | -0.81 | |||||
EBITA, 3 Yr. CAGR % | 14.84 | 22.06 | 68.44 | 6.45 | -2.2 | |||||
EBIT, 3 Yr. CAGR % | 14.84 | 22.06 | 68.44 | 6.45 | -2.2 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 14.39 | 20.73 | 94.36 | 6.81 | -2.45 | |||||
Net Income, 3 Yr. CAGR % | 14.39 | 20.73 | 94.36 | 6.81 | -2.45 | |||||
Normalized Net Income, 3 Yr. CAGR % | 14.56 | 21.95 | 69.96 | 6.83 | -2.41 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 18.01 | 25.49 | 103.04 | 12.12 | 2.21 | |||||
Accounts Receivable, 3 Yr. CAGR % | 19.72 | 12.69 | 2.5 | -1.5 | 14.1 | |||||
Inventory, 3 Yr. CAGR % | 7.28 | 8.31 | 15.07 | 9.34 | 10.62 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 25.04 | -2.14 | 3.31 | 5.93 | 8.1 | |||||
Total Assets, 3 Yr. CAGR % | 14.29 | 3.36 | 3.89 | 8 | 9.23 | |||||
Tangible Book Value, 3 Yr. CAGR % | -5.51 | 1.04 | 4.52 | 17.61 | 6.82 | |||||
Common Equity, 3 Yr. CAGR % | -5.51 | 1 | 4.46 | 17.46 | 12.67 | |||||
Cash From Operations, 3 Yr. CAGR % | 3.47 | 10.4 | 22.13 | 8.11 | 0.47 | |||||
Capital Expenditures, 3 Yr. CAGR % | -18.61 | 1.5 | 42.05 | 29.56 | 11.69 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 15.65 | 17.33 | 5.53 | 0.38 | -3.1 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 15.71 | 17.33 | 5.34 | 0.33 | -3.06 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 12.2 | 11.65 | 10.78 | 8.83 | 15.04 | |||||
Gross Profit, 5 Yr. CAGR % | 16.55 | 16.24 | 14.85 | 9.66 | 17.97 | |||||
EBITDA, 5 Yr. CAGR % | 12.53 | 12.6 | 11.13 | 8.9 | 23.12 | |||||
EBITA, 5 Yr. CAGR % | 14.58 | 15.85 | 14.46 | 11.67 | 34.28 | |||||
EBIT, 5 Yr. CAGR % | 14.58 | 15.85 | 14.46 | 11.67 | 34.28 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 19.19 | 17.48 | 14.41 | 11.21 | 45.67 | |||||
Net Income, 5 Yr. CAGR % | 19.19 | 17.48 | 14.41 | 11.21 | 45.67 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.52 | 15.87 | 14.57 | 11.76 | 34.62 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 22.49 | 21.79 | 18.93 | 15.84 | 52.49 | |||||
Accounts Receivable, 5 Yr. CAGR % | 21.4 | 14.87 | 8.84 | 9.89 | 8.93 | |||||
Inventory, 5 Yr. CAGR % | 9.69 | 8.44 | 7.95 | 9.25 | 13.76 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19 | 16.66 | 17.59 | 0.76 | 5.37 | |||||
Total Assets, 5 Yr. CAGR % | 13.3 | 13.05 | 12.33 | 4.29 | 6.58 | |||||
Tangible Book Value, 5 Yr. CAGR % | -0.35 | 1.88 | 4.67 | 5.58 | 3.63 | |||||
Common Equity, 5 Yr. CAGR % | -0.19 | 2.01 | 4.6 | 5.52 | 6.99 | |||||
Cash From Operations, 5 Yr. CAGR % | 10.8 | 13.71 | 9.08 | 3.98 | 13.15 | |||||
Capital Expenditures, 5 Yr. CAGR % | -14.34 | -6.67 | 6.39 | 4.64 | 23.42 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 34.01 | 30.14 | 9.67 | 4.82 | 6.2 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 34.05 | 30.14 | 9.67 | 4.82 | 6.11 |
- Stock Market
- Stocks
- ULTA Stock
- Financials Ulta Beauty, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















